EGFR and urothelial carcinoma: To clarify the molecular context in which ERBB2 and EGFR gene amplifications and overexpression occur we performed an in-depth study of EGFR, ERBB2, and ERBB3 alterations in relation to existing urothelial carcinoma molecular subtypes.